ELOVL5 Antikörper (AA 247-326)
Kurzübersicht für ELOVL5 Antikörper (AA 247-326) (ABIN7266928)
Target
Alle ELOVL5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 247-326
-
Verwendungszweck
- ELOVL5 Rabbit pAb
-
Sequenz
- GVIWPCTFPL GWLYFQIGYM ISLIALFTNF YIQTYNKKGA SRRKDHLKDH QNGSMAAVNG HTNSFSPLEN NVKPRKLRKD
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Polyclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 247-326 of human ELOVL5 (NP_001229757.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- ELOVL5 (ELOVL Fatty Acid Elongase 5 (ELOVL5))
-
Andere Bezeichnung
- ELOVL5
-
Hintergrund
- This gene belongs to the ELO family. It is highly expressed in the adrenal gland and testis, and encodes a multi-pass membrane protein that is localized in the endoplasmic reticulum. This protein is involved in the elongation of long-chain polyunsaturated fatty acids. Mutations in this gene have been associated with spinocerebellar ataxia-38 (SCA38). Alternatively spliced transcript variants have been found for this gene.,ELOVL5,HELO1,SCA38,dJ483K16.1,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,Cardiovascular,Lipids,Fatty Acids,ELOVL5
-
Molekulargewicht
- 9kDa/35kDa/38kDa
-
Gen-ID
- 60481
-
UniProt
- Q9NYP7
Target
-